Retrace completed - next wave up incomingChart looking good.
RSI reset… macd turning up
Next wave up incoming
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.135 AUD
−134.22 M AUD
9.01 M AUD
860.23 M
About MESOBLAST LIMITED
Sector
Industry
CEO
Silviu Itescu
Website
Headquarters
Melbourne
Founded
2004
ISIN
AU000000MSB8
FIGI
BBG000CS0BH1
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
Finer Market Points: ASX Top 10 Momentum Stocks: 4 Apr 2024ASX:MSB AMEX:GLV AMEX:MAG NYSE:MMC NYSE:MMI NYSE:FND NYSE:TPC NASDAQ:PAA NYSE:PNR AMEX:USL
Momentum leading shares are the market's best performers today. They are the fastest-growing shares on the ASX over the last 90 days. These companies can't get to be leaders without first a
$MSB - The pain just keeps goingI'm expecting a small uptick followed by prolonged investor pain. History likes to repeat itself and $MSB looks awful
MSB squeezes stubborn longs to their death.. Off topic but as an leading indicator for "market timing" is when defensive stocks return to their original strongest demand zones from their origins of a past move & are met again for another strong rally, this seems it could to be happening to MBS, time will tell!
With that said overall mark
MSB - Trade PlanMSB has been consolidating until recently when it spiked higher and pulling back currently. This could be a buying opportunity as long as its 50SMA support holds. I will be watching price action at the current levels and targeting the upper Resistance level of $2.95 with a tight stoploss below the s
MSB long setup level triggered LOOKING FOR BULLISH PA - Patience and discipline down here, will wait for price to confirm major players are within this demand zone,
Reduction in Heart Attacks, Strokes and Cardiac DeathSingle Dose of Rexlemestrocel-L Provides Substantial and Durable Reduction in Heart Attacks, Strokes and Cardiac Death in Patients With Chronic Heart Failure
results from the landmark DREAM-HF randomized controlled Phase 3 trial in 537 treated patients with chronic heart failure with reduced left v
MSB gets Fast Track from FDA Looks like price is respecting trendline / uptrend.
Price is within range. Needs to break above resistance and stay above for bullish confirmation.
Next target I would imagine a sell off unless FDA approval or some super bullish news is released and it gaps up (possible with these lower cap stock
MSB - Bullish (A Medium to Long Term Buying Opportunity)1. Price has plummeted down and stopped at exact upward sloping 50 Months Moving Average
2. Price got support exactly on the 200 Weeks Moving Average
3. Price got support at a very strong Monthly Support Level
I believe this is a great medium to long term buying buying opportunity, as price got sup
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MSB is 1.485 AUD — it has decreased by −5.71% in the past 24 hours. Watch MESOBLAST LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange MESOBLAST LIMITED stocks are traded under the ticker MSB.
MSB stock has fallen by −14.66% compared to the previous week, the month change is a 3.13% rise, over the last year MESOBLAST LIMITED has showed a 296.51% increase.
We've gathered analysts' opinions on MESOBLAST LIMITED future price: according to them, MSB price has a max estimate of 2.73 AUD and a min estimate of 1.13 AUD. Watch MSB chart and read a more detailed MESOBLAST LIMITED stock forecast: see what analysts think of MESOBLAST LIMITED and suggest that you do with its stocks.
MSB stock is 7.82% volatile and has beta coefficient of −0.26. Track MESOBLAST LIMITED stock price on the chart and check out the list of the most volatile stocks — is MESOBLAST LIMITED there?
Today MESOBLAST LIMITED has the market capitalization of 1.80 B, it has decreased by −11.52% over the last week.
Yes, you can track MESOBLAST LIMITED financials in yearly and quarterly reports right on TradingView.
MESOBLAST LIMITED is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
MSB earnings for the last half-year are −0.08 AUD per share, whereas the estimation was −0.05 AUD, resulting in a −41.64% surprise. The estimated earnings for the next half-year are −0.06 AUD per share. See more details about MESOBLAST LIMITED earnings.
MESOBLAST LIMITED revenue for the last half-year amounts to 3.76 M AUD, despite the estimated figure of 6.14 M AUD. In the next half-year revenue is expected to reach 4.54 M AUD.
MSB net income for the last half-year is −84.20 M AUD, while the previous report showed −49.87 M AUD of net income which accounts for −68.84% change. Track more MESOBLAST LIMITED financial stats to get the full picture.
No, MSB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 73.00 employees. See our rating of the largest employees — is MESOBLAST LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MESOBLAST LIMITED EBITDA is −82.63 M AUD, and current EBITDA margin is −917.74%. See more stats in MESOBLAST LIMITED financial statements.
Like other stocks, MSB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MESOBLAST LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MESOBLAST LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MESOBLAST LIMITED stock shows the buy signal. See more of MESOBLAST LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.